IIM
ABBV icon

Invariant Investment Management’s AbbVie ABBV Stock Holding History

Invariant Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Sell
1,396
-76
-5% -$16.4K 0.21% 52
2026
Q1 		$313K Sell
1,472
-12
-0.8% -$2.66K 0.19% 55
2025
Q4 		$327K Buy
+1,484
New +$338K 0.21% 58

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invariant Investment Management's ABBV Position: Q2 2026 in Review

Invariant Investment Management reduced its AbbVie (ABBV) stake by 5.2% in Q2 2026, selling an estimated $16.4K and leaving 1,396 shares worth $356K. The position accounts for 0.21% of the portfolio, ranked #52.

Invariant Investment Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 3,126 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Invariant Investment Management held 1,396 shares of AbbVie worth $356K as of Q2 2026.
  • Invariant Investment Management sold 76 AbbVie shares in Q2 2026, an estimated $16.4K.
  • AbbVie made up 0.21% of Invariant Investment Management's portfolio in Q2 2026, its #52 holding.
  • Invariant Investment Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 3,126 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Invariant Investment Management's 13F filing for Q2 2026, filed 8 Jul 2026.